Position
Quantbot Technologies LP in Xeris Biopharma Holdings, Inc.
Back to the book · All holders of XERS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$57.5K$7.85 → $5.80
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 77.6K | $609.5K | — | — | — | 0.0% |
| Q1 2026 | 28.1K | $162.8K | $5.80 | −$57.5K | −$389.2K | 0.0% |